Go To...

Pubblicazioni

Pubblicazioni su riviste censite sul Journal Citation Reports

 

  1. Maggi P, Serio G, Epifani G, Fiorentino G, Saracino A, Fico C, Perilli F, Lillo A, Ferraro S, Gargiulo M, Chirianni A, Angarano G, Pastore G. Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors. AIDS 2000; 14: 123-128.
  2. Maggi P, Lillo A, Perilli F, Maserati R, Chirianni A on behalf of the PREVALEAT group. Colour-doppler ultrasonography of carotid vessels in patients treated with antiretroviral therapy: a comparative study. AIDS 2004; 18:1023-1028.
  3. Regina G, Impedovo G, Angiletta D, Martiradonna F, Lillo A, Perilli F, Marotta V, Marzullo A, Epifani G, Fiore JR and Maggi P. Surgical experience with carotid stenosis in young HIV-1 positive patients under antiretroviral therapy: an emergine problem? Eur J Vasc Endovasc Surg. 2005 ; 29 :167-170.
  4. Maggi P, Monno R, Chirianni A, Gargiulo M, Carito V, Fumarola L, Perilli F, Lillo A, Bellacosa C, Panebianco A, Epifani G, Regina G. Role of chlamydia infection in the pathogenesis of atherosclerotic plaques in HIV-1-positive patients. In Vivo. 2006 May-Jun;20(3):409-13.
  5. Maggi P, Perilli F, Lillo A, Carito V, Epifani G, Bellacosa C, Pastore G, Regina G. An ultrasound-based comparative study on carotid plaques in HIV-positive patients vs. atherosclerotic and arteritis patients: atherosclerotic or inflammatory lesions? Coron Artery Dis. 2007 Feb;18(1):23-9.
  6. Maggi P, Maserati R, Antonelli G. Atherosclerosis in HIV patients: a new face for an old disease? AIDS Reviews 2006;8:204-9.
  7. Maggi P, Perilli F, Lillo A, Epifani G, Gargiulo M, Ferraro S, Grisorio B, Ferrara S, Carito V, Rapid progression of carotid lesions in HAART-treated HIV-1 patients. Atherosclerosis 2007; 192:407-412.
  8. Maggi P, Chirianni A, Lillo A, Perilli F, Gargiulo M, Esposito V, Bellacosa C, Pastore G, Regina G. A color doppler ultrasound-based comparative study between stavudine and non-stavudine regimens in the onset of vascular lesions in HIV-1 positive patients. In Vivo 2008; 22:489-492.
  9. Maggi P, Bellacosa C, Grattagliano V, Pastore G, Lapadula G. Functional impairment of microcirculation in HIV-positive patients: a fluxometry-based investigation, HIV Clin Trials 2008; 9:428-433.
  10. Maggi P, Perilli F, Lillo A, Volpe A, Pastore G, Regina G. B-mode Ultrasound Study of Carotid Plaques in HIV-positive Patients to Detect the Presence of Inflammatory Endothelial Lesions. Curr HIV Res. 2009; 7:541-546.
  11. Maggi P, Quirino T, Ricci E, De Socio GV, Gadaleta A, Ingrassia F, Perilli F, Lillo A, Bonfanti P. Cardiovascular risk assessment in antiretroviral-naïve HIV patients. AIDS Patient Care STDS. 2009 Oct;23(10):809-13.
  12. Maggi P, Volpe A, Bellacosa C, Pastore G, Perilli F, Lillo A, Regina G. The role of immune reconstitution in the onset of subclinical atheromasic lesions. J Acquir Immune Defic Syndr. 2009 Dec 1;52(4):524-5.
  13. Ferraro S, Paolillo S, Gargiulo M, Costanzo P, Maggi P, Chirianni A, Chiariello M, Filardi PP. Effect of antiretroviral therapy on carotid intima-media thickness in HIV-infected patients. G Ital Cardiol 2009 Sep;10(9):596-601
  14. De Socio GV, Martinelli C, Ricci E, Orofino G, Valsecchi L, Vitiello P, Martinelli L, Quirino T, Maggi P, Bonfanti P; for the HERMES study group. Relations between cardiovascular risk estimates and subclinical atherosclerosis in naive HIV patients: results from the HERMES study.Int J STD AIDS. 2010 Apr;21(4):267-272.
  15. Grattagliano V, Iannone F, Praino E, De Zio A, Riccardi MT, Carrozzo N, Covelli M, Maggi P, Lapadula G. Digital laser doppler flowmetry may discriminate “limited” from “diffuse” systemic sclerosis. Microvasc Res. 2010 Sep;80(2):221-6.
  16. De Socio GV, Ricci E, Parruti G, Maggi P, Madeddu G, Quirino T, Bonfanti P. Chronological and biological age in HIV infection. J Infect. 2010 Nov;61(5):428-30.
  17. Maggi P, Bellacosa C, Carito V, Perilli F, Lillo A, Volpe A, Trillo G, Angiletta D, Regina G, Angarano G. Cardiovascular risk factors in patients on long-term treatment with nevirapine- or efavirenz-based regimens. J Antimicrob Chemother. 2011 Apr;66(4):896-900.
  18. Ferraioli G, Tinelli C, Maggi P, Gervasoni C, Grima P, Viskovic K, Carerj S, Filice G, Filice C. Arterial stiffness evaluation in HIV-positive patients: a multicenter matched control study. Arterial Stiffness Evaluation in HIV-Infected Subjects Study Group. AJR Am J Roentgenol. 2011 Nov;197(5):1258-62.
  19. Gotti D, Cesana BM, Albini L, Calabresi A, Izzo I, Focà E, Motta D, Bellagamba R, Fezza R, Narciso P, Sidhinolfi L,Maggi P, Brianese N, Quiros-Roldan E, Guaraldi G, Torti C. Increase in Standard Cholesterol and Large HDL Particle Subclasses in Antiretroviral-Naïve Patients Prescribed Efavirenz Compared to Atazanavir/Ritonavir. HIV Clin Trials. 2012 Sep-Oct;13(5):245-55.
  20. Schillaci G,Maggi P, Madeddu G, Pucci G, Mazzotta E, Penco G, Orofino G, Menzaghi B, Rusconi S, Carenzi L, Celesia BM, Martinelli C, Bonfanti P, De Socio GV; for the CISAI Study Group. Symmetric ambulatory arterial stiffness index and 24-h pulse pressure in HIV infection: results of a nationwide cross-sectional study. J Hypertens. 2013, 31:560–567.
  21. Di Biagio A, Rosso R,Maggi P, Mazzei D, Bernardini C, Nulvesu L, Parisini A, Nicco E, De Carli F, Rodriguez G, Viscoli C. Inflammation markers correlate with common carotid intima-media thickness in patients perinatally infected with human immunodeficiency virus 1. J Ultrasound Med. 2013 May;32(5):763-8.
  22. Maggi P, De Socio GVL, Volpe A, Lenoci F, Altizio S1, Leone AS, Bellacosa C, Angarano G and Antonelli G. Organ Damage in HIV-Positive Patients with High Blood Pressure. J AIDS Clin Res 2013, 4:10.
  23. Li Vecchi V, Maggi P, Rizzo M, Montalto G.The Metabolic Syndrome and HIV Infection.
  24. Curr Pharm Des. 2014;20(31): 4975-5003.
  25. De Socio GV, Ricci E, Maggi P, Parruti G, Pucci G, Di Biagio A, Calza L, Orofino G, Carenzi L, Cecchini E, Madeddu G, Quirino T, Schillaci G; CISAI study group. Prevalence, Awareness, Treatment, and Control Rate of Hypertension in HIV-Infected Patients: The HIV-HY Study.
  26. Am J Hypertens. 2014 Feb;27(2):222-8.
  27. De Socio GV, Parruti G, Ricci E, Maggi P, Celesia BM, Penco G, Martinelli C, Franzetti M, Di Biagio A, Bonfanti P, Pucci G, Schillaci G; (for the CISAI study group. ) Decreasing cardiovascular risk in HIV infection between 2005 and 2011. AIDS. 2014 Feb 20;28(4):609-12.
  28. Bellacosa C, Maggi P, Volpe A, Altizio S, Ladisa N, Cicalini S, Viglietti R, Chirianni A, Bellazzi L, Zanaboni D, Maserati R, Martinelli C, Corsi P, Sofia S, Celesia M, Sozio F, Abbrescia N, Angarano G. Epi-aortic lesions, pathologic FMD, endothelial activation and inflammatory markers in advanced naïve HIV-infected patients starting ART therapy. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19545. doi: 10.7448/IAS.17.4.19545.
  29. De Socio GV, Ricci E, Parruti G, Calza L,Maggi P, Celesia BM, Orofino G, Madeddu G, Martinelli C, Menzaghi B, Taramasso L, Penco G, Carenzi L, Franzetti M, Bonfanti P. Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study. 2016 Oct;44(5):589-97.
  30. De Socio GV, Ricci E, Maggi P, Parruti G, Celesia BM, Orofino G, Madeddu G, Martinelli C, Menzaghi B, Taramasso L, Bonfanti P, Pucci G, Schillaci G; CISAI study group.Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients: the HIV and Hypertension Study. J Hypertens. 2017 Feb;35(2):409-416.
  31. Maggi P, Bruno G, Perilli F, Saracino A, Volpe A, Santoro C, Ladisa N, Angarano G. Effects of Therapy with Maraviroc on the Carotid Intima Media Thickness in HIV-1/HCV Co-infected Patients. In Vivo. 2017 01-02;31(1):125-131.
  32. Maggi P, De Socio GV, Cicalini S, D’Abbraccio M, Dettorre G, Di Biagio A, Martinelli C, Nunnari G, Rusconi S, Sighinolfi L, Spagnuolo V, Squillace N. Use of statins and aspirin to prevent cardiovascular disease among HIV-positive patients. A survey among Italian HIV physicians. New Microbiol. 2017 Apr;40(2):139-142.
  33. Maggi P, Bellacosa C, Leone A, Volpe A, Ricci ED, Ladisa N, Cicalini S, Grilli E, Viglietti R, Chirianni A, Bellazzi LI, Maserati R, Martinelli C, Corsi P, Celesia BM, Sozio F, Angarano G.Cardiovascular risk in advanced naïve HIV-infected patients starting antiretroviral therapy: Comparison of three different regimens – PREVALEAT II cohort. Atherosclerosis. 2017 Aug; 263:398-404.
  34. Maggi P, Di Biagio A, Rusconi S, Cicalini S, D’Abbraccio M, d’Ettorre G, Martinelli C, Nunnari G, Sighinolfi L, Spagnuolo V, Squillace N. Cardiovascular risk and dyslipidemia among persons living with HIV: a review. BMC Infect Dis. 2017 Aug 9;17(1):551. doi: 10.1186/s12879-017-2626-z.